Vanguard Plus 7
|
-
|
V/NRP/03/1610
|
Zoetis Belgium S.A., Beļģija
|
QI07AI02
|
dogs
|
Vairāk
|
Medicinal product information
Pharmaceutical form: |
lyophilisate and solvent for solution for injection
|
International name (active substance): |
Live attenuated Canine Distemper virus, strain Snyder Hill, Live attenuated Canine Adenovirus type 2 (CAV2), strain Manhattan, Live attenuated Canine Parainfluenza virus, strain NL-CPI-5, Live attenuated Canine Parvovirus, strain NL-35-D, Inactivated Leptospira canicola, strain C-51, Inactivated Leptospira icterohaemorrhagiae, strain NADL (11403)
|
Distribution category: |
To be supplied only on veterinary prescription
|
Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
Date of authorisation/renewal: |
08-Dec-2008
|
Marketing authorisation valid until: |
Unlimited time period
|
Marketing authorisation procedure: |
NRP
|
Package leaflet: |
[DOCX] 2212122_LI (22-Dec-2022)
|
Labelling text: |
[DOCX] 221222_M (22-Dec-2022)
|
Summary of product characteristics: |
[DOCX] 221222_ZA (22-Dec-2022)
|
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/NRP/03/1610-01 |
1 deva |
25 |
Flakons, 1 deva |
-
|
V/NRP/03/1610-02 |
1 deva |
1 |
Flakons, 1 deva |
-
|
V/NRP/03/1610-03 |
1 deva |
10 |
Flakons, 1 deva |
-
|
V/NRP/03/1610-04 |
1 deva |
100 |
Flakons, 1 deva |
-
|
|